DRESS and AGEP Reactions to Iodinated Contrast Media: A French Case Series

• Published in: The journal of allergy and clinical immunology in practice (Cambridge, MA)
• Main Authors: Soria, Angèle, Amsler, Emmanuelle, Bernier, Claire, Milpied, Brigitte, Tétart, Florence, Morice, Cécile, Dezoteux, Frédéric, Ferrier-Le Bouedec, Marie-Christine, Barbaud, Annick, Staumont-Sallé, Delphine, Assier, Haudrey
• Format: Journal Article
• Language: English
• Published: United States 01.08.2021
• Subjects: Acute generalized exanthematous pustulosis; Cutaneous adverse drug reaction; Drug reaction with eosinophilia and systemic symptoms; Skin tests; Iodinated contrast media
• ISSN: 2213-2201
• DOI: 10.1016/j.jaip.2021.02.060

Drug reactions with eosinophilia and systemic symptoms (DRESSs) and acute generalized exanthematous pustulosis (AGEP) are potentially severe cutaneous adverse drug reactions. To describe the clinical findings and sensitization profiles of DRESS and AGEP patients who had been administered iodinated contrast media (ICM). All adult patients in the dermatologist's French Investigators for Skin Adverse Reactions to Drugs (FISARD) network diagnosed with a DRESS or AGEP highly suspected to have been caused by an ICM were included retrospectively. Thirteen DRESS patients and 19 AGEP patients who had been administered ICM were included, and the median delay in DRESS and AGEP occurrence after ICM administration was short, 4 and 1 days, respectively. Five AGEP patients had systemic involvement. A high cosensitization rate (46%) was observed among the DRESS patients, mainly with beta-lactam antibiotics. Overall, 77% of our patients were sensitized to several ICM. Patch tests identified the suspected ICM for 21 cases (72%). The retrospective nature, the limited number of subjects, the absence of a control group of healthy individuals, and the lack of detailed information on previous exposure to sensitizing drugs are limitations of this study. We report a large series of DRESSs and AGEPs related to ICM administration. Skin tests appear useful for diagnosis and potentially to identify alternative ICM.